31440155|t|The Precursor to Glutathione (GSH), gamma-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Abeta40 Oligomers in Human Astrocytes.
31440155|a|Glutathione (GSH) is one of the most abundant thiol antioxidants in cells. Many chronic and age-related diseases are associated with a decline in cellular GSH levels or impairment in the catalytic activity of the GSH biosynthetic enzyme glutamate cysteine ligase (GCL). gamma-glutamylcysteine (GGC), a precursor to glutathione (GSH), can replenish depleted GSH levels under oxidative stress conditions, by circumventing the regulation of GSH biosynthesis and providing the limiting substrate. Soluble amyloid-beta (Abeta) oligomers have been shown to induce oxidative stress, synaptic dysfunction and memory deficits which have been reported in Alzheimer's disease (AD). Calcium ions, which are increased with age and in AD, have been previously reported to enhance the formation of Abeta40 oligomers, which have been casually associated with the pathogenesis of the underlying neurodegenerative condition. In this study, we examined the potential beneficial effects of GGC against exogenous Abeta40 oligomers on biomarkers of apoptosis and cell death, oxidative stress, and neuroinflammation, in human astrocytes. Treatment with Abeta40 oligomers significantly reduced the cell viability and apoptosis of astrocyte brain cultures and increased oxidative modifications of DNA, lipids, and protein, enhanced pro-inflammatory cytokine release and increased the activity of the proteolytic matrix metalloproteinase enzyme, matric metalloproteinase (MMP)-2 and reduced the activity of MMP-9 after 24 h. Co-treatment of Abeta40 oligomers with GGC at 200 muM increased the activity of the antioxidant enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPx) and led to significant increases in the levels of the total antioxidant capacity (TAC) and GSH and reduced the GSSG/GSH ratio. GGC also upregulated the level of the anti-inflammatory cytokine IL-10 and reduced the levels of the pro-inflammatory cytokines (TNF-alpha, IL-6, and IL-1beta) and attenuated the changes in metalloproteinase activity in oligomeric Abeta40-treated astrocytes. Our data provides renewed insight on the beneficial effects of increased GSH levels by GGC in human astrocytes, and identifies yet another potential therapeutic strategy to attenuate the cytotoxic effects of Abeta oligomers in AD.
31440155	17	28	Glutathione	Chemical	MESH:D005978
31440155	30	33	GSH	Chemical	MESH:D005978
31440155	36	58	gamma-Glutamylcysteine	Chemical	MESH:C017341
31440155	60	63	GGC	Chemical	MESH:C017341
31440155	91	97	Damage	Disease	MESH:D020263
31440155	102	119	Neuroinflammation	Disease	MESH:D000090862
31440155	152	157	Human	Species	9606
31440155	170	181	Glutathione	Chemical	MESH:D005978
31440155	183	186	GSH	Chemical	MESH:D005978
31440155	216	221	thiol	Chemical	MESH:D013438
31440155	325	328	GSH	Chemical	MESH:D005978
31440155	383	386	GSH	Chemical	MESH:D005978
31440155	407	432	glutamate cysteine ligase	Gene	2729
31440155	434	437	GCL	Gene	2729
31440155	440	462	gamma-glutamylcysteine	Chemical	MESH:C017341
31440155	464	467	GGC	Chemical	MESH:C017341
31440155	485	496	glutathione	Chemical	MESH:D005978
31440155	498	501	GSH	Chemical	MESH:D005978
31440155	527	530	GSH	Chemical	MESH:D005978
31440155	608	611	GSH	Chemical	MESH:D005978
31440155	671	683	amyloid-beta	Gene	351
31440155	685	690	Abeta	Gene	351
31440155	746	766	synaptic dysfunction	Disease	MESH:C536122
31440155	771	786	memory deficits	Disease	MESH:D008569
31440155	815	834	Alzheimer's disease	Disease	MESH:D000544
31440155	836	838	AD	Disease	MESH:D000544
31440155	841	848	Calcium	Chemical	MESH:D002118
31440155	891	893	AD	Disease	MESH:D000544
31440155	1048	1075	neurodegenerative condition	Disease	MESH:D019636
31440155	1140	1143	GGC	Chemical	MESH:C017341
31440155	1245	1262	neuroinflammation	Disease	MESH:D000090862
31440155	1267	1272	human	Species	9606
31440155	1447	1453	lipids	Chemical	MESH:D008055
31440155	1481	1493	inflammatory	Disease	MESH:D007249
31440155	1590	1622	matric metalloproteinase (MMP)-2	Gene	4313
31440155	1651	1656	MMP-9	Gene	4318
31440155	1708	1711	GGC	Chemical	MESH:C017341
31440155	1773	1793	superoxide dismutase	Gene	6647
31440155	1795	1798	SOD	Gene	6647
31440155	1924	1927	GSH	Chemical	MESH:D005978
31440155	1944	1948	GSSG	Chemical	MESH:D019803
31440155	1949	1952	GSH	Chemical	MESH:D005978
31440155	1960	1963	GGC	Chemical	MESH:C017341
31440155	2003	2015	inflammatory	Disease	MESH:D007249
31440155	2025	2030	IL-10	Gene	3586
31440155	2065	2077	inflammatory	Disease	MESH:D007249
31440155	2089	2098	TNF-alpha	Gene	7124
31440155	2100	2104	IL-6	Gene	3569
31440155	2110	2118	IL-1beta	Gene	3553
31440155	2292	2295	GSH	Chemical	MESH:D005978
31440155	2306	2309	GGC	Chemical	MESH:C017341
31440155	2313	2318	human	Species	9606
31440155	2406	2415	cytotoxic	Disease	MESH:D064420
31440155	2427	2432	Abeta	Gene	351
31440155	2446	2448	AD	Disease	MESH:D000544
31440155	Negative_Correlation	MESH:C017341	MESH:D020263
31440155	Negative_Correlation	MESH:C017341	3569
31440155	Negative_Correlation	MESH:C017341	MESH:D000090862
31440155	Association	MESH:D005978	2729
31440155	Negative_Correlation	MESH:C017341	MESH:D007249
31440155	Negative_Correlation	MESH:C017341	4318
31440155	Association	MESH:D007249	3569
31440155	Association	MESH:D002118	MESH:D019636
31440155	Positive_Correlation	MESH:C536122	351
31440155	Positive_Correlation	MESH:C017341	6647
31440155	Positive_Correlation	MESH:D002118	MESH:D000544
31440155	Positive_Correlation	MESH:D008569	351
31440155	Negative_Correlation	MESH:C017341	3553
31440155	Association	MESH:D007249	3553
31440155	Negative_Correlation	MESH:C017341	7124
31440155	Negative_Correlation	MESH:C017341	MESH:D019803
31440155	Positive_Correlation	MESH:C017341	3586
31440155	Positive_Correlation	MESH:C017341	MESH:D005978
31440155	Association	MESH:D000544	351

